| Characteristic | Cost in million Canadian dollars |
|---|---|
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
| - | - |
The chart is not accessible to screen readers. Please switch to the table view to access the data.
Download
Source
More information
Region
Canada
Survey time period
FY 2021/2022
Supplementary notes
Select public drug plans include Alberta, Saskatchewan, Manitoba, Ontario, New Brunswick, Nova Scotia, Prince Edward Island, British Columbia, Newfoundland and Labrador, and Yukon.
This analysis only includes data for beneficiaries that met their deductible and received public reimbursement. public reimbursement.
Citation formats
